{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:19:50Z","timestamp":1784204390029,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T00:00:00Z","timestamp":1677974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T00:00:00Z","timestamp":1677974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2018-2137"],"award-info":[{"award-number":["PICT-2018-2137"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Lung cancer is one of the most frequently diagnosed cancers characterized by high mortality, metastatic potential, and recurrence. Deregulated gene expression of lung cancer, likewise in many other solid tumors, accounts for their cell heterogeneity and plasticity. S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1), also known as Inositol triphosphate (IP(3)) receptor-binding protein released with IP(3) (IRBIT), plays roles in many cellular functions, including autophagy and apoptosis but AHCYL1 role in lung cancer is largely unknown.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here, we analyzed the expression of AHCYL1 in Non-Small Cell Lung Cancer (NSCLC) cells from RNA-seq public data and surgical specimens, which revealed that AHCYL1 expression is downregulated in tumors and inverse correlated to proliferation marker Ki67 and the stemness signature expression. AHCYL1-silenced NSCLC cells showed enhanced stem-like properties in vitro, which correlated with higher expression levels of stem markers POU5F1 and CD133. Also, the lack of AHCYL1 enhanced tumorigenicity and angiogenesis in mouse xenograft models highlighting stemness features.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These findings indicate that AHCYL1 is a negative regulator in NSCLC tumorigenesis by modulating cell differentiation state and highlighting AHCYL1 as a potential prognostic biomarker for lung cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13062-023-00364-y","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T08:02:21Z","timestamp":1678003341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) inhibits lung cancer tumorigenesis by regulating cell plasticity"],"prefix":"10.1186","volume":"18","author":[{"given":"Melina","family":"Mu\u00f1oz-Bernart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Budnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Pioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Defranchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Parrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn M.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Perez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,5]]},"reference":[{"issue":"7689","key":"364_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"issue":"5","key":"364_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"February","key":"364_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.suronc.2020.04.017","volume":"34","author":"S Shenoy","year":"2020","unstructured":"Shenoy S. Cell plasticity in cancer: a complex interplay of genetic, epigenetic mechanisms and tumor micro-environment. Surg Oncol. 2020;34(February):154\u201362. https:\/\/doi.org\/10.1016\/j.suronc.2020.04.017.","journal-title":"Surg Oncol"},{"issue":"2","key":"364_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2016.01.012","volume":"372","author":"L MacDonagh","year":"2016","unstructured":"MacDonagh L, Gray SG, Breen E, et al. Lung cancer stem cells: the root of resistance. Cancer Lett. 2016;372(2):147\u201356. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.012.","journal-title":"Cancer Lett"},{"issue":"1","key":"364_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-017-0674-z","volume":"16","author":"J Jen","year":"2017","unstructured":"Jen J, Tang Y, Lu Y, Lin C, Lai W, Wang Y. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression. Mol Cancer. 2017;16(1):104. https:\/\/doi.org\/10.1186\/s12943-017-0674-z.","journal-title":"Mol Cancer"},{"issue":"4","key":"364_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1510\/icvts.2008.193995","volume":"8","author":"G Karoubi","year":"2009","unstructured":"Karoubi G, Gugger M, Schmid R, Dutly A. Work in progress report\u2014thoracic oncologic OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention. Interact Cardiovasc Thorac Surg. 2009;8(4):393\u20137. https:\/\/doi.org\/10.1510\/icvts.2008.193995.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"8","key":"364_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/bioinformatics\/btv726","volume":"32","author":"RG Parra","year":"2016","unstructured":"Parra RG, Rohr CO, Koile D, Perez-Castro C, Yankilevich P. INSECT 2.0: a web-server for genome-wide cis-regulatory modules prediction. Bioinformatics. 2016;32(8):1229\u201331. https:\/\/doi.org\/10.1093\/bioinformatics\/btv726.","journal-title":"Bioinformatics"},{"issue":"22","key":"364_CR8","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/bioinformatics\/btt506","volume":"29","author":"CO Rohr","year":"2013","unstructured":"Rohr CO, Parra RG, Yankilevich P, Perez-Castro C. INSECT: IN-silico SEarch for Co-occurring Transcription factors. Bioinformatics. 2013;29(22):2852\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btt506.","journal-title":"Bioinformatics"},{"issue":"18","key":"364_CR9","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-15-3159","volume":"76","author":"NE Ferreyra Solari","year":"2016","unstructured":"Ferreyra Solari NE, Belforte FS, Canedo L, et al. The NSL chromatin-modifying complex subunit KANSL2 regulates cancer stem\u2013like properties in glioblastoma that contribute to tumorigenesis. Cancer Res. 2016;76(18):5383\u201394. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3159.","journal-title":"Cancer Res"},{"key":"364_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/bies.20772","volume":"4","author":"B Devogelaere","year":"2008","unstructured":"Devogelaere B, Sammels E, De SH. The IRBIT domain adds new functions to the AHCY family. BioEssays. 2008;4:642\u201352. https:\/\/doi.org\/10.1002\/bies.20772.","journal-title":"BioEssays"},{"issue":"6","key":"364_CR11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.molcel.2006.05.017","volume":"22","author":"H Ando","year":"2006","unstructured":"Ando H, Mizutani A, Kiefer H, Tsuzurugi D, Michikawa T, Mikoshiba K. IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor. Mol Cell. 2006;22(6):795\u2013806. https:\/\/doi.org\/10.1016\/j.molcel.2006.05.017.","journal-title":"Mol Cell"},{"issue":"6203","key":"364_CR12","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1126\/science.1251550","volume":"345","author":"A Arnaoutov","year":"2014","unstructured":"Arnaoutov A, Dasso M. IRBIT is a novel regulator of ribonucleotide reductase in higher eukaryotes. Science. 2014;345(6203):1512\u20135. https:\/\/doi.org\/10.1126\/science.1251550.","journal-title":"Science"},{"key":"364_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.19896","volume":"5","author":"B Bonneau","year":"2016","unstructured":"Bonneau B, Ando H, Kawaai K, Hirose M, Takahashi-Iwanaga H, Mikoshiba K. IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact. Elife. 2016;5:1\u201327. https:\/\/doi.org\/10.7554\/eLife.19896.","journal-title":"Elife"},{"issue":"1","key":"364_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1172\/JCI36983","volume":"119","author":"D Yang","year":"2009","unstructured":"Yang D, Shcheynikov N, Zeng W, et al. IRBIT coordinates epithelial fluid and HCO3\u2212 secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct. J Clin Invest. 2009;119(1):193\u2013202. https:\/\/doi.org\/10.1172\/JCI36983.","journal-title":"J Clin Invest"},{"issue":"22","key":"364_CR15","first-page":"6698","volume":"62","author":"R Wittig","year":"2002","unstructured":"Wittig R, Nessling M, Will RD, et al. Candidate genes for cross-resistance against DNA-damaging drugs. Cancer Res. 2002;62(22):6698\u2013705.","journal-title":"Cancer Res"},{"issue":"8","key":"364_CR16","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.21873\/anticanres.13569","volume":"39","author":"N Nakazawa","year":"2019","unstructured":"Nakazawa N, Ogata K, Yokobori T, et al. Low IRBIT levels are associated with chemo-resistance in gastric cancer patients. Anticancer Res. 2019;39(8):4111\u20136. https:\/\/doi.org\/10.21873\/anticanres.13569.","journal-title":"Anticancer Res"},{"issue":"2","key":"364_CR17","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1080\/15548627.2021.1924038","volume":"18","author":"W Huang","year":"2021","unstructured":"Huang W, Li N, Zhang Y, Wang X, Yin M, Lei QY. AHCYL1 senses SAH to inhibit autophagy through interaction with PIK3C3 in an MTORC1-independent manner. Autophagy. 2021;18(2):3019\u2013319. https:\/\/doi.org\/10.1080\/15548627.2021.1924038.","journal-title":"Autophagy"},{"issue":"4","key":"364_CR18","doi-asserted-by":"publisher","first-page":"101774","DOI":"10.1016\/j.jbc.2022.101774","volume":"298","author":"L Wischhof","year":"2022","unstructured":"Wischhof L, Adhikari A, Mondal M, et al. Unbiased proteomic profiling reveals the IP3R modulator AHCYL1\/IRBIT as a novel interactor of microtubule-associated protein tau. J Biol Chem. 2022;298(4):101774. https:\/\/doi.org\/10.1016\/j.jbc.2022.101774.","journal-title":"J Biol Chem"},{"key":"364_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ejcb.2017.05.002","volume":"96","author":"I Grbe\u0161a","year":"2017","unstructured":"Grbe\u0161a I, Kalo A, Beluzic R, et al. Mutations in S-adenosylhomocysteine hydrolase (AHCY) affect its nucleocytoplasmic distribution and capability to interact with S-adenosylhomocysteine hydrolase-like 1 protein. Eur J Cell Biol. 2017;96:579\u201390. https:\/\/doi.org\/10.1016\/j.ejcb.2017.05.002.","journal-title":"Eur J Cell Biol"},{"issue":"3","key":"364_CR20","doi-asserted-by":"publisher","first-page":"100954","DOI":"10.1016\/j.isci.2020.100954","volume":"23","author":"A Arnaoutov","year":"2020","unstructured":"Arnaoutov A, Lee H, Plevock Haase K, et al. IRBIT directs differentiation of intestinal stem cell progeny to maintain tissue homeostasis. iScience. 2020;23(3):100954. https:\/\/doi.org\/10.1016\/j.isci.2020.100954.","journal-title":"iScience"},{"issue":"5","key":"364_CR21","first-page":"1016","volume":"7","author":"YA Fouad","year":"2017","unstructured":"Fouad YA, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res. 2017;7(5):1016\u201336.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"364_CR22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, Yip LY, Hui J, et al. Methionine is a metabolic dependency of tumor-initiating cells. Nat Med. 2019;25(5):825\u201337. https:\/\/doi.org\/10.1038\/s41591-019-0423-5.","journal-title":"Nat Med"},{"issue":"13","key":"364_CR23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.15252\/embj.201488166","volume":"34","author":"SG Dann","year":"2015","unstructured":"Dann SG, Ryskin M, Barsotti AM, et al. Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2. EMBO J. 2015;34(13):1773\u201385. https:\/\/doi.org\/10.15252\/embj.201488166.","journal-title":"EMBO J"},{"issue":"2","key":"364_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","volume":"1","author":"AM Intlekofer","year":"2019","unstructured":"Intlekofer AM, Finley LWS. Metabolic signatures of cancer cells and stem cells. Nat Metab. 2019;1(2):177\u201388. https:\/\/doi.org\/10.1038\/s42255-019-0032-0.","journal-title":"Nat Metab"},{"key":"364_CR25","unstructured":"WHO Classification of Tumours Editorial Board Thoracic Tumours. 2021. 5th ed. Lyon: International Agency for Research on Cancer. https:\/\/publications.iarc.fr\/595."},{"key":"364_CR26","unstructured":"Schneider F, Beasley MB, Dacic S, Butnor KJ. Protocol for the examination of resection specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. 2022. Version: 4.3.0.0. College of American Pathologists (CAP) www.cap.org\/cancerprotocols (Accessed July 2022)."},{"issue":"2","key":"364_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"364_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"364_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173(2):338-354.e15. https:\/\/doi.org\/10.1016\/j.cell.2018.03.034.","journal-title":"Cell"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"408","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;408:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"1\u20132","key":"364_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1\u20132):70\u20138. https:\/\/doi.org\/10.1016\/j.jim.2009.06.008.","journal-title":"J Immunol Methods"},{"issue":"7","key":"364_CR32","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLOS Biol. 2020;18(7):e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410.","journal-title":"PLOS Biol"},{"issue":"4","key":"364_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/jso.2930310402","volume":"31","author":"DM Euhus","year":"1986","unstructured":"Euhus DM, Hudd C, Laregina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol. 1986;31(4):229\u201334. https:\/\/doi.org\/10.1002\/jso.2930310402.","journal-title":"J Surg Oncol"},{"issue":"12","key":"364_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-biochem-061516-044952.Metabolite","volume":"176","author":"W Lu","year":"2017","unstructured":"Lu W, Su X, Klein M, Lewis I, Fiehn O, Rabinowitz J. Metabolite measurement: pitfalls to avoid and practices to follow. Annu Rev Biochem. 2017;176(12):139\u201348. https:\/\/doi.org\/10.1146\/annurev-biochem-061516-044952.Metabolite.","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"364_CR35","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/bjc.2014.402","volume":"111","author":"A Warth","year":"2014","unstructured":"Warth A, Cortis J, Soltermann A, et al. Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. Br J Cancer. 2014;111(6):1222\u20139. https:\/\/doi.org\/10.1038\/bjc.2014.402.","journal-title":"Br J Cancer"},{"issue":"2","key":"364_CR36","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3892\/etm.2017.4632","volume":"14","author":"Y Liu","year":"2017","unstructured":"Liu Y, Yao X, Zhang Q, et al. Expression of kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis. Exp Ther Med. 2017;14(2):1351\u20136. https:\/\/doi.org\/10.3892\/etm.2017.4632.","journal-title":"Exp Ther Med"},{"key":"364_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev.pathol.1.110304.100103","volume":"1","author":"II Wistuba","year":"2006","unstructured":"Wistuba II, Gazdar AF. Lung cancer preneoplasia. Annu Rev Pathol. 2006;1:331\u201348. https:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100103.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"364_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-021-01920-8","volume":"23","author":"X Huang","year":"2022","unstructured":"Huang X, Guan W, Xiang B, Wang W, Xie Y, Zheng J. MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model. Respir Res. 2022;23(1):1\u201312. https:\/\/doi.org\/10.1186\/s12931-021-01920-8.","journal-title":"Respir Res"},{"key":"364_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.addr.2015.08.005","volume":"99","author":"K Kise","year":"2016","unstructured":"Kise K, Kinugasa-Katayama Y, Takakura N. Tumor microenvironment for cancer stem cells. Adv Drug Deliv Rev. 2016;99:197\u2013205. https:\/\/doi.org\/10.1016\/j.addr.2015.08.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"364_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jtho.2016.03.015","volume":"11","author":"F De Marinis","year":"2016","unstructured":"De Marinis F, Bria E, Ciardiello F, et al. International experts panel meeting of the Italian association of thoracic oncology on antiangiogenetic drugs for non-small cell lung cancer: realities and hopes. J Thorac Oncol. 2016;11(7):1153\u201369. https:\/\/doi.org\/10.1016\/j.jtho.2016.03.015.","journal-title":"J Thorac Oncol"},{"key":"364_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-018-9613-x","author":"P Nowak-Sliwinska","year":"2018","unstructured":"Nowak-Sliwinska P, Alitalo K, Allen E, et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018. https:\/\/doi.org\/10.1007\/s10456-018-9613-x.","journal-title":"Angiogenesis"},{"issue":"4","key":"364_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41419-019-1507-3","volume":"19","author":"L Tedesco","year":"2019","unstructured":"Tedesco L, Elguero B, Pacin DG, et al. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME. Cell Death Dis. 2019;19(4):266. https:\/\/doi.org\/10.1038\/s41419-019-1507-3.","journal-title":"Cell Death Dis"},{"issue":"12","key":"364_CR43","doi-asserted-by":"publisher","first-page":"958","DOI":"10.18632\/oncoscience.280","volume":"2","author":"S Fern\u00e1ndez-Arroyo","year":"2016","unstructured":"Fern\u00e1ndez-Arroyo S, Cuy\u00e0s E, Bosch-Barrera J, Alarc\u00f3n T, Joven J, Menendez JA. Activation of the methylation cycle in cells reprogrammed into a stem cell-like state. Oncoscience. 2016;2(12):958\u201367. https:\/\/doi.org\/10.18632\/oncoscience.280.","journal-title":"Oncoscience"},{"issue":"7","key":"364_CR44","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1258\/ebm.2012.011433","volume":"237","author":"W Jeong","year":"2012","unstructured":"Jeong W, Kim HS, Kim YB, et al. Paradoxical expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women. Exp Biol Med. 2012;237(7):758\u201367. https:\/\/doi.org\/10.1258\/ebm.2012.011433.","journal-title":"Exp Biol Med"},{"issue":"7","key":"364_CR45","first-page":"2127","volume":"5","author":"SJ Park","year":"2015","unstructured":"Park SJ, Kong HK, Kim YS, Lee YS, Park JH. Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest. Am J Cancer Res. 2015;5(7):2127\u201338.","journal-title":"Am J Cancer Res"},{"issue":"14","key":"364_CR46","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.1073\/pnas.1915582117","volume":"117","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Cheng X, Cheng Y, et al. O-GlcNAcylation regulates the methionine cycle to promote pluripotency of stem cells. PNAS. 2020;117(14):7755\u201363. https:\/\/doi.org\/10.1073\/pnas.1915582117.","journal-title":"PNAS"},{"issue":"7","key":"364_CR47","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/1759-7714.12647","volume":"9","author":"S Li","year":"2018","unstructured":"Li S, Shen L, Chen KN. Association between H3K4 methylation and cancer prognosis: a meta-analysis. Thorac Cancer. 2018;9(7):794\u20139. https:\/\/doi.org\/10.1111\/1759-7714.12647.","journal-title":"Thorac Cancer"}],"updated-by":[{"DOI":"10.1186\/s13062-023-00367-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000}}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-023-00364-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00364-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T06:09:40Z","timestamp":1680070180000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-023-00364-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1186\/s13062-023-00364-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13062-023-00367-9","asserted-by":"object"}]},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,5]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13062-023-00367-9","URL":"https:\/\/doi.org\/10.1186\/s13062-023-00367-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was collected according to the Fundaci\u00f3n Favaloro hospital\u2019s institutional review board (in compliance with the October 2013 Helsinki Declaration). The research protocol was approved by the Bioethics Committee of the Fundaci\u00f3n Favaloro DDI (1473) 0719. Animal experiments were performed according to ARRIVE guidelines and approved by the Ethical Committee on Animal Care and Use (CICUAL), University of Buenos Aires, Argentina (No. 110-2019) and IBioBA-CONICET (2021-03-PC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}